Live Price Coverage: Castlight Health Inc’s Stock Is Buy After Today’s Big Increase

Live Price Coverage: Castlight Health Inc's Stock Is Buy After Today's Big Increase

The stock of Castlight Health Inc (NYSE:CSLT) is a huge mover today! About 211,186 shares traded hands. Castlight Health Inc (NYSE:CSLT) has risen 43.48% since April 14, 2016 and is uptrending. It has outperformed by 38.79% the S&P500.
The move comes after 5 months positive chart setup for the $508.15 million company. It was reported on Nov, 16 by We have $7.20 PT which if reached, will make NYSE:CSLT worth $238.83 million more.

Castlight Health Inc (NYSE:CSLT) Ratings Coverage

Out of 6 analysts covering Castlight Health (NYSE:CSLT), 3 rate it a “Buy”, 0 “Sell”, while 3 “Hold”. This means 50% are positive. Castlight Health has been the topic of 12 analyst reports since October 9, 2015 according to StockzIntelligence Inc. The firm earned “Buy” rating on Thursday, November 5 by Stifel Nicolaus. First Analysis upgraded the stock to “Overweight” rating in Friday, October 9 report. The rating was downgraded by Leerink Swann to “Mkt Perform” on Thursday, November 5. The rating was maintained by Topeka Capital Markets on Thursday, February 18 with “Buy”. The firm has “Mkt Perform” rating by FBR Capital given on Wednesday, November 18. The rating was maintained by FBR Capital on Wednesday, May 11 with “Mkt Perform”. The rating was initiated by Topeka Capital Markets with “Buy” on Wednesday, December 16. The firm has “Buy” rating by Stifel Nicolaus given on Thursday, February 18.

According to Zacks Investment Research, “Castlight Health, Inc. operates as a provider of cloud-based software. Its enables enterprises to gain control over their rapidly escalating health care costs. The Company’s Enterprise Healthcare Cloud allows its customers to conquer the complexity of the existing health care system by providing personalized, actionable information to their employees, implementing technology-enabled benefit designs and integrating disparate systems and applications. Castlight Health, Inc. is headquartered in San Francisco, California.”

Insitutional Activity: The institutional sentiment increased to 1.54 in 2016 Q2. Its up 0.54, from 1 in 2016Q1. The ratio improved, as 6 funds sold all Castlight Health Inc shares owned while 22 reduced positions. 10 funds bought stakes while 33 increased positions. They now own 40.64 million shares or 0.35% more from 40.50 million shares in 2016Q1.
Schwab Charles Investment Mgmt accumulated 0% or 95,094 shares. Ny State Common Retirement Fund has 48,231 shares for 0% of their US portfolio. Citadel Advsr Ltd accumulated 0% or 182,078 shares. Raymond James & Assocs holds 0% or 79,650 shares in its portfolio. Bragg Fin Advisors Incorporated has invested 0.01% of its portfolio in Castlight Health Inc (NYSE:CSLT). Citigroup Inc accumulated 0% or 5,330 shares. Prudential Public Limited Co last reported 0.05% of its portfolio in the stock. State Street holds 0% of its portfolio in Castlight Health Inc (NYSE:CSLT) for 587,988 shares. Alyeska Grp Ltd Partnership has 0.03% invested in the company for 766,568 shares. Stifel Fin Corp accumulated 38,330 shares or 0% of the stock. Metropolitan Life Insurance reported 34,226 shares or 0% of all its holdings. Blackrock Gru Limited last reported 0% of its portfolio in the stock. Barclays Public Ltd Liability Com accumulated 86 shares or 0% of the stock. Wellcome Tru (The) As Trustee Of The Wellcome Tru has 6.57M shares for 0.59% of their US portfolio. Moreover, Bank & Trust Of Montreal Can has 0% invested in Castlight Health Inc (NYSE:CSLT) for 500 shares.

Insider Transactions: Since May 17, 2016, the stock had 0 insider buys, and 6 sales for $103,382 net activity. Rende Jonathan sold 8,286 shares worth $35,186. 4,526 shares were sold by McCracken John, worth $18,042. $14,028 worth of shares were sold by Nolan Mangini Siobhan on Monday, August 15. DOYLE JOHN C sold 3,373 shares worth $14,241. Colella Giovanni M. sold $15,857 worth of stock or 3,761 shares.

More notable recent Castlight Health Inc (NYSE:CSLT) news were published by: which released: “Why Castlight Health Inc. Is SkyrocketingToday” on May 18, 2016, also with their article: “Why Castlight Health Inc Is Surging Today” published on August 09, 2016, published: “Very Negative Outlook For Castlight Health” on February 03, 2016. More interesting news about Castlight Health Inc (NYSE:CSLT) were released by: and their article: “Castlight Health Jumped 12.1% in August — Here’s Why” published on September 09, 2016 as well as‘s news article titled: “Castlight Health Remains On The Same Bad Track” with publication date: March 03, 2016.

CSLT Company Profile

Castlight Health, Inc., incorporated on January 31, 2008, offers a health benefits platform that engages employees to make healthcare decisions, and enables employers to communicate and measure their benefit programs. The Firm operates through cloud products segment. The Company’s technology offering aggregates data and applies analytics to make healthcare data transparent. The Company’s products deliver employee engagement and enable employers to integrate benefit programs into a single platform available to employees and their families. The Company’s health benefits platform engages external data and its substantial user base to provide a single, end-to-end solution that integrates benefit programs and engages employees through personalized and relevant communications. The Company’s offering provides employers the opportunity to communicate, measure, and get value out of their benefits and programs on a real-time basis. It obtains external data from a range of sources, such as healthcare providers, insurance companies, governmental agencies and quality-monitoring organizations, as well as internal data it generates from the usage of its products. It applies data science techniques, including predictive modeling and epidemiological analytics that engage its database to drive insights.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Leave a Comment